Correlation between mRNAseq expression and clinical features
Acute Myeloid Leukemia (Primary blood derived cancer - Peripheral blood)
17 October 2014 | analyses__2014_10_17
Maintainer Information
Citation Information
doi:10.7908/C10V8BPT
Maintained by Juok Cho (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2014): Correlation between mRNAseq expression and clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C10V8BPT
Overview
Introduction

This pipeline uses various statistical tests to identify mRNAs whose log2 expression levels correlated to selected clinical features.

Summary

Testing the association between 17276 genes and 4 clinical features across 173 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 3 clinical features related to at least one genes.

- 24 genes correlated to 'Time to Death'.

- PWWP2A|114825 , MYB|4602 , CLINT1|9685 , ADSS|159 , HSDL1|83693 , ...

- 46 genes correlated to 'AGE'.

- GBP2|2634 , PI4K2A|55361 , FBXO32|114907 , C7ORF58|79974 , SLC22A16|85413 , ...

- 3 genes correlated to 'GENDER'.

- NCRNA00183|554203 , HDHD1A|8226 , CD24|100133941

- No genes correlated to 'RACE'

Results
Overview of the results

Complete statistical result table is provided in Supplement Table 1

Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at P value < 0.05 and Q value < 0.3.

Clinical feature | Statistical test | Significant genes | Associated with |  | Associated with |
--- | --- | --- | --- | --- | --- | ---
Time to Death | Cox regression test | N=24 | shorter survival | N=8 | longer survival | N=16
AGE | Spearman correlation test | N=46 | older | N=35 | younger | N=11
GENDER | Wilcoxon test | N=3 | male | N=3 | female | N=0
RACE | Kruskal-Wallis test | N=0 |  |  |  |

Clinical variable #1: 'Time to Death'

24 genes related to 'Time to Death'.

Table S1. Basic characteristics of clinical feature: 'Time to Death'

Time to Death | Duration (Months) | 0.9-94.1 (median=12)
| censored | N = 57
| death | N = 94
| Significant markers | N = 24
| associated with shorter survival | 8
| associated with longer survival | 16

List of top 10 genes differentially expressed by 'Time to Death'

Table S2. Get Full Table List of top 10 genes significantly associated with 'Time to Death' by Cox regression test

| HazardRatio | Wald_P | Q | C_index
--- | --- | --- | --- | ---
PWWP2A|114825 | 0.37 | 6.386e-07 | 0.011 | 0.336
MYB|4602 | 0.54 | 6.724e-07 | 0.012 | 0.343
CLINT1|9685 | 0.32 | 1.4e-06 | 0.024 | 0.368
ADSS|159 | 0.29 | 2.173e-06 | 0.038 | 0.334
HSDL1|83693 | 0.46 | 2.639e-06 | 0.046 | 0.345
PTP4A3|11156 | 1.4 | 2.701e-06 | 0.047 | 0.646
GMCL1|64395 | 0.45 | 4.064e-06 | 0.07 | 0.39
C2ORF67|151050 | 0.55 | 4.498e-06 | 0.078 | 0.338
LOC100130264|100130264 | 0.78 | 4.63e-06 | 0.08 | 0.343
IL2RA|3559 | 1.23 | 4.705e-06 | 0.081 | 0.633

Clinical variable #2: 'AGE'

46 genes related to 'AGE'.

Table S3. Basic characteristics of clinical feature: 'AGE'

AGE | Mean (SD) | 55.27 (16)
| Significant markers | N = 46
| pos. correlated | 35
| neg. correlated | 11

List of top 10 genes differentially expressed by 'AGE'

Table S4. Get Full Table List of top 10 genes significantly correlated to 'AGE' by Spearman correlation test

| SpearmanCorr | corrP | Q
--- | --- | --- | ---
GBP2|2634 | 0.4101 | 2.1e-08 | 0.000363
PI4K2A|55361 | 0.406 | 2.98e-08 | 0.000515
FBXO32|114907 | 0.368 | 6.309e-07 | 0.0109
C7ORF58|79974 | 0.372 | 6.373e-07 | 0.011
SLC22A16|85413 | -0.3624 | 9.597e-07 | 0.0166
HK2|3099 | -0.3611 | 1.059e-06 | 0.0183
PPARD|5467 | 0.3581 | 1.314e-06 | 0.0227
TMEM117|84216 | 0.3708 | 1.616e-06 | 0.0279
STK16|8576 | 0.3544 | 1.716e-06 | 0.0296
KLRF1|51348 | 0.3514 | 2.129e-06 | 0.0368

Clinical variable #3: 'GENDER'

3 genes related to 'GENDER'.

Table S5. Basic characteristics of clinical feature: 'GENDER'

GENDER | Labels | N
| FEMALE | 80
| MALE | 93
| Significant markers | N = 3
| Higher in MALE | 3
| Higher in FEMALE | 0

List of 3 genes differentially expressed by 'GENDER'

Table S6. Get Full Table List of 3 genes differentially expressed by 'GENDER'. 19 significant gene(s) located in sex chromosomes is(are) filtered out.

| W(pos if higher in 'MALE') | wilcoxontestP | Q | AUC
--- | --- | --- | --- | ---
NCRNA00183|554203 | 1159 | 6.406e-15 | 1.11e-10 | 0.8442
HDHD1A|8226 | 1995 | 1.518e-07 | 0.00262 | 0.7319
CD24|100133941 | 5374 | 4.798e-07 | 0.00828 | 0.7223

Clinical variable #4: 'RACE'

No gene related to 'RACE'.

Table S7. Basic characteristics of clinical feature: 'RACE'

RACE | Labels | N
| ASIAN | 2
| BLACK OR AFRICAN AMERICAN | 13
| WHITE | 156
| Significant markers | N = 0

Methods & Data
Input

- Expresson data file = LAML-TB.uncv2.mRNAseq_RSEM_normalized_log2.txt

- Clinical data file = LAML-TB.merged_data.txt

- Number of patients = 173

- Number of genes = 17276

- Number of clinical features = 4

Survival analysis

For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels

Correlation analysis

For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R

Student's t-test analysis

For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R

ANOVA analysis

For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

- Analysis Results (MD5 checksum)

- Auxiliary Data (MD5 checksum)

- MAGE-TAB File (MD5 checksum)

References
[1] Andersen and Gill, Cox's regression model for counting processes, a large sample study, Annals of Statistics 10(4):1100-1120 (1982)
[2] Spearman, C, The proof and measurement of association between two things, Amer. J. Psychol 15:72-101 (1904)
[3] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)
[4] Howell, D, Statistical Methods for Psychology. (5th ed.), Duxbury Press:324-5 (2002)
[5] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)
Copyright © 2015 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle